\n\n

The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patients

Ozempic, Wegovy, and similar drugs may deliver excellent health value, but covering them for millions of eligible patients could overwhelm insurance budgets. Researchers say better long-term support is needed and warn that low-cost compounded versions may carry serious safety risks.

Related Posts

Scientists discover a hidden problem with this popular sugar substitute

Sorbitol, a sugar alcohol commonly used in sugar-free candy, gum, and other low-calorie foods, may not be as harmless as it seems. Researchers at Washington University in St. Louis found…

Scientists discover a hidden problem with this popular sugar substitute

Sorbitol, a sugar alcohol commonly used in sugar-free candy, gum, and other low-calorie foods, may not be as harmless as it seems. Researchers at Washington University in St. Louis found…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Jordan arrests US journalist for ‘sedition’

Jordan arrests US journalist for ‘sedition’

Tunisia’s quiet crackdown explained

Tunisia’s quiet crackdown explained

‘Despair and fear’: Amira Hass on how Israeli policy is laying the groundwork for mass expulsion

‘Despair and fear’: Amira Hass on how Israeli policy is laying the groundwork for mass expulsion

9/11 – 24th anniversary | Why young Americans know nothing about the ‘war on terror’

9/11 – 24th anniversary | Why young Americans know nothing about the ‘war on terror’

Tayab Ali explains why UK sanctions will ‘terrify’ Netanyahu’s government

Tayab Ali explains why UK sanctions will ‘terrify’ Netanyahu’s government

Hurricane Lowell expected to impact Hawaii overnight

Hurricane Lowell expected to impact Hawaii overnight